Global Blood Preparation Market: by Product, by Type, by Application - Forecast to 2032
7.3%
CAGR (2026-2032)
53.6 USD Bn.
Market Size
310
Report Pages
156
Market Tables
Overview
Blood Preparation Market is expected to reach USD 87.77 Bn. at a CAGR of 7.3 % during the forecast period 2032.
Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology :- Request Free Sample Report
The growth is coupled with the factors including increasing aging population, advancement in the technology, and increasing patient awareness level. Increasing blood disorder prevalence and rising emergency surgeries in hospitals also expected to drive the market through the forecast period. Further, increased acceptance of advanced blood testing technologies has accelerated accurate diagnosis of haemato logical disorders. Other factors including growing demand for blood and its component due to the increase in target diseases, accidents, and surgeries is expected to drive the market for blood preparation market through the forecast period.
In addition, growing emergency cases in the emergency departments coupled with rising demand for blood transfusion is expected to fuel the Global Blood Preparation Market growth. Organizations such as the National Institutes of Health (NIH) and the Centre for Disease Control (CDC) are taking initiatives for raising awareness levels via programs that aim to prevent thrombosis-associated complications in early stages and thus, drive the Global Blood Preparation Market for blood preparation through the forecast period.
Blood Preparation Market Segment Analysis
In the Blood Preparation Market, Pulmonary Embolism is expected to dominate the application segment in 2025. This dominance is driven by the rising incidence of venous thromboembolism and cardiovascular disorders worldwide. Pulmonary embolism requires rapid diagnosis and effective anticoagulant or thrombolytic therapy, increasing the demand for blood-related preparations used during treatment and monitoring. Additionally, growing awareness, improved diagnostic techniques, and increasing hospital admissions for clot-related conditions further support the segment’s leading market share.
Blood Preparation Market Regional Analysis
APAC is also considered a rapidly dominating and fastest-growing region in the Blood Preparation Market in 2025. Growth is driven by the large patient population, rising cases of chronic and cardiovascular diseases, and increasing surgical procedures. Expanding healthcare infrastructure, improving blood banking systems, and growing government initiatives for voluntary blood donation in countries like China, India, and Japan further support the region’s strong market growth.
The objective of the report is to present comprehensive Global Blood Preparation Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Global Blood Preparation Marketket North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Blood Preparation Marketket North America for Asia Pacific size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Blood Preparation Marketket North America for Asia Pacific make the report investor’s guide.
Blood Preparation Market Scope: Inquire before buying
| Blood Preparation Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 53.6 USD Billion |
| Forecast Period 2026-2032 CAGR: | 7.3% | Market Size in 2032: | 87.77 USD Billion |
| Segments Covered: | by Product | Whole Blood Red Cells Granulocytes Plasma Plateletso Blood Components Whole Blood Components Packed Red Cells Leukocyte Reduced Red Blood Cells Frozen Plasma Platelet Concentrate |
|
| by Type | Platelet Aggregation Inhibitors Glycoprotein Inhibitors COX Inhibitors ADP Antagonists Phosphodiesterase Inhibitorso Fibrinolytics Tissue Plasminogen Activator (tPA) Streptokinase Urokinaseo Anticoagulants Heparins |
||
| by Application | Thrombocytosis Pulmonary Embolism Renal Impairment Others |
||
| by End User | Hospitals Clinics Diagnostic Centers / Laboratories Blood Banks Research Institutes |
||
Blood Preparation Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players / Competitores Proflies Coverd Blood Preparation Market Report in Strategic Perspective
1. Celgene Corp
2. AstraZeneca Co.
3. Sanofi Aventis Leo Pharma Inc.
4. Bristol-Myers Squibb Co
5. Baxter Healthcare Corp.
6. Pfizer Inc.
7. Shandong East Chemical Industry Co
8. GlaxoSmithKline PLC
9. Bristol-Myers Squibb Company
10. Merc & Co., Inc.
11. Novartis Pharmaceuticals
12. AbbVie Inc.
13. Johnson & Johnson Pvt. Ltd.
14. Amgen Inc.
15. Teva pharmaceutical Industries Ltd.
16. Takeda Pharmaceutical Co. Ltd.
17. Astellas Pharma Inc
18. Eli Lilly
19. F.Hoffmann-La Roche Ltd.
20. Joh
21. Roche Holding AG
22. Novartis AG
23. Thermo Fisher Scientific Inc.
24. Laboratory Corporation of America Holdings
Table of Contents
1. Blood Preparation Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Blood Preparation Market: Competitive Landscape
2.1. MMR Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.3.1. Company Name
2.3.2. Business Segment
2.3.3. End-user Segment
2.3.4. Revenue (2025)
2.3.5. Company Locations
2.4. Leading Blood Preparation Market Companies, by market capitalization
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Blood Preparation Market: Dynamics
3.1. Blood Preparation Market Trends by Region
3.1.1. North America Blood Preparation Market Trends
3.1.2. Europe Blood Preparation Market Trends
3.1.3. Asia Pacific Blood Preparation Market Trends
3.1.4. Middle East and Africa Blood Preparation Market Trends
3.1.5. South America Blood Preparation Market Trends
3.2. Blood Preparation Market Dynamics by Region
3.2.1. North America
3.2.1.1. North America Blood Preparation Market Drivers
3.2.1.2. North America Blood Preparation Market Restraints
3.2.1.3. North America Blood Preparation Market Opportunities
3.2.1.4. North America Blood Preparation Market Challenges
3.2.2. Europe
3.2.2.1. Europe Blood Preparation Market Drivers
3.2.2.2. Europe Blood Preparation Market Restraints
3.2.2.3. Europe Blood Preparation Market Opportunities
3.2.2.4. Europe Blood Preparation Market Challenges
3.2.3. Asia Pacific
3.2.3.1. Asia Pacific Blood Preparation Market Drivers
3.2.3.2. Asia Pacific Blood Preparation Market Restraints
3.2.3.3. Asia Pacific Blood Preparation Market Opportunities
3.2.3.4. Asia Pacific Blood Preparation Market Challenges
3.2.4. Middle East and Africa
3.2.4.1. Middle East and Africa Blood Preparation Market Drivers
3.2.4.2. Middle East and Africa Blood Preparation Market Restraints
3.2.4.3. Middle East and Africa Blood Preparation Market Opportunities
3.2.4.4. Middle East and Africa Blood Preparation Market Challenges
3.2.5. South America
3.2.5.1. South America Blood Preparation Market Drivers
3.2.5.2. South America Blood Preparation Market Restraints
3.2.5.3. South America Blood Preparation Market Opportunities
3.2.5.4. South America Blood Preparation Market Challenges
3.3. PORTER's Five Forces Analysis
3.4. PESTLE Analysis
3.5. Technology Roadmap
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis For Blood Preparation Industry
3.8. Analysis of Government Schemes and Initiatives For Blood Preparation Industry
3.9. Blood Preparation Market Trade Analysis
3.10. The Global Pandemic Impact on Blood Preparation Market
4. Blood Preparation Market: Global Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
4.1. Blood Preparation Market Size and Forecast, by Product (2025-2032)
4.1.1. Whole Blood
4.1.2. Red Cells
4.1.3. Granulocytes
4.1.4. Plasma
4.1.5. Plateletso Blood Components
4.1.6. Whole Blood Components
4.1.7. Packed Red Cells
4.1.8. Leukocyte Reduced Red Blood Cells
4.1.9. Frozen Plasma
4.1.10. Platelet Concentrate
4.2. Blood Preparation Market Size and Forecast, by Type (2025-2032)
4.2.1. Platelet Aggregation Inhibitors
4.2.2. Glycoprotein Inhibitors
4.2.3. COX Inhibitors
4.2.4. ADP Antagonists
4.2.5. Phosphodiesterase Inhibitorso Fibrinolytics
4.2.6. Tissue Plasminogen Activator (tPA)
4.2.7. Streptokinase
4.2.8. Urokinaseo Anticoagulants
4.2.9. Heparins
4.3. Blood Preparation Market Size and Forecast, by Application (2025-2032)
4.3.1. Thrombocytosis
4.3.2. Pulmonary Embolism
4.3.3. Renal Impairment
4.3.4. Others
4.4. Blood Preparation Market Size and Forecast, by End User (2025-2032)
4.4.1. Hospitals
4.4.2. Clinics
4.4.3. Diagnostic Centers / Laboratories
4.4.4. Blood Banks
4.4.5. Research Institutes
4.5. Blood Preparation Market Size and Forecast, by Region (2025-2032)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Blood Preparation Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
5.1. North America Blood Preparation Market Size and Forecast, by Product (2025-2032)
5.1.1. Whole Blood
5.1.2. Red Cells
5.1.3. Granulocytes
5.1.4. Plasma
5.1.5. Plateletso Blood Components
5.1.6. Whole Blood Components
5.1.7. Packed Red Cells
5.1.8. Leukocyte Reduced Red Blood Cells
5.1.9. Frozen Plasma
5.1.10. Platelet Concentrate
5.2. North America Blood Preparation Market Size and Forecast, by Type (2025-2032)
5.2.1. Platelet Aggregation Inhibitors
5.2.2. Glycoprotein Inhibitors
5.2.3. COX Inhibitors
5.2.4. ADP Antagonists
5.2.5. Phosphodiesterase Inhibitorso Fibrinolytics
5.2.6. Tissue Plasminogen Activator (tPA)
5.2.7. Streptokinase
5.2.8. Urokinaseo Anticoagulants
5.2.9. Heparins
5.3. North America Blood Preparation Market Size and Forecast, by Application (2025-2032)
5.3.1. Thrombocytosis
5.3.2. Pulmonary Embolism
5.3.3. Renal Impairment
5.3.4. Others
5.4. North America Blood Preparation Market Size and Forecast, by End User (2025-2032)
5.4.1. Hospitals
5.4.2. Clinics
5.4.3. Diagnostic Centers / Laboratories
5.4.4. Blood Banks
5.4.5. Research Institutes
5.5. North America Blood Preparation Market Size and Forecast, by Country (2025-2032)
5.5.1. United States
5.5.1.1. United States Blood Preparation Market Size and Forecast, by Product (2025-2032)
5.5.1.1.1. Whole Blood
5.5.1.1.2. Red Cells
5.5.1.1.3. Granulocytes
5.5.1.1.4. Plasma
5.5.1.1.5. Plateletso Blood Components
5.5.1.1.6. Whole Blood Components
5.5.1.1.7. Packed Red Cells
5.5.1.1.8. Leukocyte Reduced Red Blood Cells
5.5.1.1.9. Frozen Plasma
5.5.1.1.10. Platelet Concentrate
5.5.1.2. United States Blood Preparation Market Size and Forecast, by Type (2025-2032)
5.5.1.2.1. Platelet Aggregation Inhibitors
5.5.1.2.2. Glycoprotein Inhibitors
5.5.1.2.3. COX Inhibitors
5.5.1.2.4. ADP Antagonists
5.5.1.2.5. Phosphodiesterase Inhibitorso Fibrinolytics
5.5.1.2.6. Tissue Plasminogen Activator (tPA)
5.5.1.2.7. Streptokinase
5.5.1.2.8. Urokinaseo Anticoagulants
5.5.1.2.9. Heparins
5.5.1.3. United States Blood Preparation Market Size and Forecast, by Application (2025-2032)
5.5.1.3.1. Thrombocytosis
5.5.1.3.2. Pulmonary Embolism
5.5.1.3.3. Renal Impairment
5.5.1.3.4. Others
5.5.1.4. United States Blood Preparation Market Size and Forecast, by End User (2025-2032)
5.5.1.4.1. Hospitals
5.5.1.4.2. Clinics
5.5.1.4.3. Diagnostic Centers / Laboratories
5.5.1.4.4. Blood Banks
5.5.1.4.5. Research Institutes
5.5.2. Canada
5.5.2.1. Canada Blood Preparation Market Size and Forecast, by Product (2025-2032)
5.5.2.1.1. Whole Blood
5.5.2.1.2. Red Cells
5.5.2.1.3. Granulocytes
5.5.2.1.4. Plasma
5.5.2.1.5. Plateletso Blood Components
5.5.2.1.6. Whole Blood Components
5.5.2.1.7. Packed Red Cells
5.5.2.1.8. Leukocyte Reduced Red Blood Cells
5.5.2.1.9. Frozen Plasma
5.5.2.1.10. Platelet Concentrate
5.5.2.2. Canada Blood Preparation Market Size and Forecast, by Type (2025-2032)
5.5.2.2.1. Platelet Aggregation Inhibitors
5.5.2.2.2. Glycoprotein Inhibitors
5.5.2.2.3. COX Inhibitors
5.5.2.2.4. ADP Antagonists
5.5.2.2.5. Phosphodiesterase Inhibitorso Fibrinolytics
5.5.2.2.6. Tissue Plasminogen Activator (tPA)
5.5.2.2.7. Streptokinase
5.5.2.2.8. Urokinaseo Anticoagulants
5.5.2.2.9. Heparins
5.5.2.3. Canada Blood Preparation Market Size and Forecast, by Application (2025-2032)
5.5.2.3.1. Thrombocytosis
5.5.2.3.2. Pulmonary Embolism
5.5.2.3.3. Renal Impairment
5.5.2.3.4. Others
5.5.2.4. Canada Blood Preparation Market Size and Forecast, by End User (2025-2032)
5.5.2.4.1. Hospitals
5.5.2.4.2. Clinics
5.5.2.4.3. Diagnostic Centers / Laboratories
5.5.2.4.4. Blood Banks
5.5.2.4.5. Research Institutes
5.5.3. Mexico
5.5.3.1. Mexico Blood Preparation Market Size and Forecast, by Product (2025-2032)
5.5.3.1.1. Whole Blood
5.5.3.1.2. Red Cells
5.5.3.1.3. Granulocytes
5.5.3.1.4. Plasma
5.5.3.1.5. Plateletso Blood Components
5.5.3.1.6. Whole Blood Components
5.5.3.1.7. Packed Red Cells
5.5.3.1.8. Leukocyte Reduced Red Blood Cells
5.5.3.1.9. Frozen Plasma
5.5.3.1.10. Platelet Concentrate
5.5.3.2. Mexico Blood Preparation Market Size and Forecast, by Type (2025-2032)
5.5.3.2.1. Platelet Aggregation Inhibitors
5.5.3.2.2. Glycoprotein Inhibitors
5.5.3.2.3. COX Inhibitors
5.5.3.2.4. ADP Antagonists
5.5.3.2.5. Phosphodiesterase Inhibitorso Fibrinolytics
5.5.3.2.6. Tissue Plasminogen Activator (tPA)
5.5.3.2.7. Streptokinase
5.5.3.2.8. Urokinaseo Anticoagulants
5.5.3.2.9. Heparins
5.5.3.3. Mexico Blood Preparation Market Size and Forecast, by Application (2025-2032)
5.5.3.3.1. Thrombocytosis
5.5.3.3.2. Pulmonary Embolism
5.5.3.3.3. Renal Impairment
5.5.3.3.4. Others
5.5.3.4. Mexico Blood Preparation Market Size and Forecast, by End User (2025-2032)
5.5.3.4.1. Hospitals
5.5.3.4.2. Clinics
5.5.3.4.3. Diagnostic Centers / Laboratories
5.5.3.4.4. Blood Banks
5.5.3.4.5. Research Institutes
6. Europe Blood Preparation Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
6.1. Europe Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.2. Europe Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.3. Europe Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.4. Europe Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5. Europe Blood Preparation Market Size and Forecast, by Country (2025-2032)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.1.2. United Kingdom Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.1.3. United Kingdom Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.1.4. United Kingdom Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.2. France
6.5.2.1. France Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.2.2. France Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.2.3. France Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.2.4. France Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.3. Germany
6.5.3.1. Germany Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.3.2. Germany Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.3.3. Germany Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.3.4. Germany Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.4. Italy
6.5.4.1. Italy Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.4.2. Italy Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.4.3. Italy Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.4.4. Italy Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.5. Spain
6.5.5.1. Spain Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.5.2. Spain Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.5.3. Spain Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.5.4. Spain Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.6. Sweden
6.5.6.1. Sweden Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.6.2. Sweden Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.6.3. Sweden Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.6.4. Sweden Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.7. Austria
6.5.7.1. Austria Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.7.2. Austria Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.7.3. Austria Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.7.4. Austria Blood Preparation Market Size and Forecast, by End User (2025-2032)
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Blood Preparation Market Size and Forecast, by Product (2025-2032)
6.5.8.2. Rest of Europe Blood Preparation Market Size and Forecast, by Type (2025-2032)
6.5.8.3. Rest of Europe Blood Preparation Market Size and Forecast, by Application (2025-2032)
6.5.8.4. Rest of Europe Blood Preparation Market Size and Forecast, by End User (2025-2032)
7. Asia Pacific Blood Preparation Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
7.1. Asia Pacific Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.2. Asia Pacific Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.3. Asia Pacific Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.4. Asia Pacific Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5. Asia Pacific Blood Preparation Market Size and Forecast, by Country (2025-2032)
7.5.1. China
7.5.1.1. China Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.1.2. China Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.1.3. China Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.1.4. China Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.2. S Korea
7.5.2.1. S Korea Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.2.2. S Korea Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.2.3. S Korea Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.2.4. S Korea Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.3. Japan
7.5.3.1. Japan Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.3.2. Japan Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.3.3. Japan Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.3.4. Japan Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.4. India
7.5.4.1. India Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.4.2. India Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.4.3. India Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.4.4. India Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.5. Australia
7.5.5.1. Australia Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.5.2. Australia Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.5.3. Australia Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.5.4. Australia Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.6. Indonesia
7.5.6.1. Indonesia Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.6.2. Indonesia Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.6.3. Indonesia Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.6.4. Indonesia Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.7. Malaysia
7.5.7.1. Malaysia Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.7.2. Malaysia Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.7.3. Malaysia Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.7.4. Malaysia Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.8. Vietnam
7.5.8.1. Vietnam Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.8.2. Vietnam Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.8.3. Vietnam Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.8.4. Vietnam Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.9. Taiwan
7.5.9.1. Taiwan Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.9.2. Taiwan Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.9.3. Taiwan Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.9.4. Taiwan Blood Preparation Market Size and Forecast, by End User (2025-2032)
7.5.10. Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific Blood Preparation Market Size and Forecast, by Product (2025-2032)
7.5.10.2. Rest of Asia Pacific Blood Preparation Market Size and Forecast, by Type (2025-2032)
7.5.10.3. Rest of Asia Pacific Blood Preparation Market Size and Forecast, by Application (2025-2032)
7.5.10.4. Rest of Asia Pacific Blood Preparation Market Size and Forecast, by End User (2025-2032)
8. Middle East and Africa Blood Preparation Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
8.1. Middle East and Africa Blood Preparation Market Size and Forecast, by Product (2025-2032)
8.2. Middle East and Africa Blood Preparation Market Size and Forecast, by Type (2025-2032)
8.3. Middle East and Africa Blood Preparation Market Size and Forecast, by Application (2025-2032)
8.4. Middle East and Africa Blood Preparation Market Size and Forecast, by End User (2025-2032)
8.5. Middle East and Africa Blood Preparation Market Size and Forecast, by Country (2025-2032)
8.5.1. South Africa
8.5.1.1. South Africa Blood Preparation Market Size and Forecast, by Product (2025-2032)
8.5.1.2. South Africa Blood Preparation Market Size and Forecast, by Type (2025-2032)
8.5.1.3. South Africa Blood Preparation Market Size and Forecast, by Application (2025-2032)
8.5.1.4. South Africa Blood Preparation Market Size and Forecast, by End User (2025-2032)
8.5.2. GCC
8.5.2.1. GCC Blood Preparation Market Size and Forecast, by Product (2025-2032)
8.5.2.2. GCC Blood Preparation Market Size and Forecast, by Type (2025-2032)
8.5.2.3. GCC Blood Preparation Market Size and Forecast, by Application (2025-2032)
8.5.2.4. GCC Blood Preparation Market Size and Forecast, by End User (2025-2032)
8.5.3. Nigeria
8.5.3.1. Nigeria Blood Preparation Market Size and Forecast, by Product (2025-2032)
8.5.3.2. Nigeria Blood Preparation Market Size and Forecast, by Type (2025-2032)
8.5.3.3. Nigeria Blood Preparation Market Size and Forecast, by Application (2025-2032)
8.5.3.4. Nigeria Blood Preparation Market Size and Forecast, by End User (2025-2032)
8.5.4. Rest of ME&A
8.5.4.1. Rest of ME&A Blood Preparation Market Size and Forecast, by Product (2025-2032)
8.5.4.2. Rest of ME&A Blood Preparation Market Size and Forecast, by Type (2025-2032)
8.5.4.3. Rest of ME&A Blood Preparation Market Size and Forecast, by Application (2025-2032)
8.5.4.4. Rest of ME&A Blood Preparation Market Size and Forecast, by End User (2025-2032)
9. South America Blood Preparation Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
9.1. South America Blood Preparation Market Size and Forecast, by Product (2025-2032)
9.2. South America Blood Preparation Market Size and Forecast, by Type (2025-2032)
9.3. South America Blood Preparation Market Size and Forecast, by Application (2025-2032)
9.4. South America Blood Preparation Market Size and Forecast, by End User (2025-2032)
9.5. South America Blood Preparation Market Size and Forecast, by Country (2025-2032)
9.5.1. Brazil
9.5.1.1. Brazil Blood Preparation Market Size and Forecast, by Product (2025-2032)
9.5.1.2. Brazil Blood Preparation Market Size and Forecast, by Type (2025-2032)
9.5.1.3. Brazil Blood Preparation Market Size and Forecast, by Application (2025-2032)
9.5.1.4. Brazil Blood Preparation Market Size and Forecast, by End User (2025-2032)
9.5.2. Argentina
9.5.2.1. Argentina Blood Preparation Market Size and Forecast, by Product (2025-2032)
9.5.2.2. Argentina Blood Preparation Market Size and Forecast, by Type (2025-2032)
9.5.2.3. Argentina Blood Preparation Market Size and Forecast, by Application (2025-2032)
9.5.2.4. Argentina Blood Preparation Market Size and Forecast, by End User (2025-2032)
9.5.3. Rest Of South America
9.5.3.1. Rest Of South America Blood Preparation Market Size and Forecast, by Product (2025-2032)
9.5.3.2. Rest Of South America Blood Preparation Market Size and Forecast, by Type (2025-2032)
9.5.3.3. Rest Of South America Blood Preparation Market Size and Forecast, by Application (2025-2032)
9.5.3.4. Rest Of South America Blood Preparation Market Size and Forecast, by End User (2025-2032)
10. Company Profile: Key Players
10.1. Celgene Corp
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Scale of Operation (small, medium, and large)
10.1.7. Details on Partnership
10.1.8. Regulatory Accreditations and Certifications Received by Them
10.1.9. Awards Received by the Firm
10.1.10. Recent Developments
10.2. AstraZeneca Co.
10.3. Sanofi Aventis Leo Pharma Inc.
10.4. Bristol-Myers Squibb Co
10.5. Baxter Healthcare Corp.
10.6. Pfizer Inc.
10.7. Shandong East Chemical Industry Co
10.8. GlaxoSmithKline PLC
10.9. Bristol-Myers Squibb Company
10.10. Merc & Co.
10.11. Novartis Pharmaceuticals
10.12. AbbVie Inc.
10.13. Johnson & Johnson Pvt. Ltd.
10.14. Amgen Inc.
10.15. Teva pharmaceutical Industries Ltd.
10.16. Takeda Pharmaceutical Co. Ltd.
10.17. Astellas Pharma Inc
10.18. Eli Lilly
10.19. F.Hoffmann-La Roche Ltd.
10.20. Joh
10.21. Roche Holding AG
10.22. Novartis AG
10.23. Thermo Fisher Scientific Inc.
10.24. Laboratory Corporation of America Holdings
11. Key Findings
12. Industry Recommendations
13. Blood Preparation Market: Research Methodology
14. Terms and Glossary